✦ LIBER ✦

Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms

✍ Scribed by Omlin, Aurelius; Pezaro, Carmel; Mukherji, Deborah; Mulick Cassidy, Amy; Sandhu, Shahneen; Bianchini, Diletta; Olmos, David; Ferraldeschi, Roberta; Maier, Gal; Thompson, Emilda; Parker, Chris; Attard, Gerhardt; de Bono, Johann

Book ID: 123055980
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 167 KB
Volume: 64
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2012.12.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Updated Prognostic Model for Predicting

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

✍ Halabi, S.; Lin, C.-Y.; Kelly, W. K.; Fizazi, K. S.; Moul, J. W.; Kaplan, E. B.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 261 KB

The effect of clinical trial participati

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

✍ Jatinder Goyal; Philipp Nuhn; Peng Huang; Prachi Tyagi; Daniel Oh; Michael A. Ca 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Circulating Tumor Cell Counts Are Progno

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

✍ Goldkorn, A.; Ely, B.; Quinn, D. I.; Tangen, C. M.; Fink, L. M.; Xu, T.; Twardow 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 180 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

7061 POSTER Assessment of Bone Remodelin

7061 POSTER Assessment of Bone Remodeling Markers and Their Relevance as Prognostic Factors for Overall Survival (OS) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients (Pts) Treated With Sunitinib (S) After Docetaxel Failure – a Prospective Study

✍ Maruani, G.M.; Elaidi, E.R.; Gachet, J.G.; Kempf, E.K.; Brizard, M.B.; Banu, E.B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

101 Updated analysis of radium-223 dichl

101 Updated analysis of radium-223 dichloride (Ra-223) impact on pain, skeletal-related events (SRE), and survival from the phase 3 randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) and bone metastases

✍ Heinrich, D.; Helle, S.I.; Chodacki, A.; Wiechno, P.; Garcia-Vargas, J.; Staudac 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 110 KB